We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Coronary Clot Aspiration Provides No MI Survival Benefit

By HospiMedica International staff writers
Posted on 02 Feb 2016
Thrombectomy did not improve outcomes for myocardial infarct (MI) patients presenting after symptom onset, according to a new study. More...


Researchers at University College London (UCL; United Kingdom), the University of Manchester (United Kingdom), and other institutions conducted a retrospective study based on a UK national registry to examine thrombectomy use in ST-segment elevation MI (STEMI) patients and relationship to overall mortality. In all, 98,176 patients treated via percutaneous coronary intervention (PCI) were grouped on the basis of whether they received thrombectomy or not; subgroups of simple (manual aspiration) and complex (mechanical) thrombectomy were also evaluated.

The results showed no significant mortality difference between the overall thrombectomy group and the no thrombectomy group, either at 30 days or at one year. Likewise, no difference was seen between the simple thrombectomy versus no thrombectomy. The complex thrombectomy group, on the other hand, demonstrated significantly higher mortality at one-year follow-up. The researchers observed that thrombectomy use markedly increased in the United Kingdom between 2008 and 2010, but plateaued thereafter at slightly below 50% of all primary PCI cases. The study was published in the January 2016 issue of JACC: Cardiovascular Interventions.

“Our large observational study does not provide evidence to support the hypothesis that selective thrombectomy in primary PCI is associated with lower mortality,” concluded lead author Alex Sirker, MB BChir, and colleagues. “Our findings are in keeping with other negative clinical outcomes from two recent large randomized controlled trials studying routine thrombectomy use in STEMI.”

“Thrombus removal remains an intuitively valid concept; however, thrombus removal is more complex than initially appreciated,” added Dharam Kumbhani, MD, of the University of Texas Southwestern Medical Center (Dallas, USA) and Anthony Bavry, MD, of the University of Florida, (Gainesville, USA), in a related editorial. “Future studies will need to similarly rigorously evaluate the role of selective thrombectomy versus no thrombectomy, determine more effective thrombectomy devices, and better discriminate appropriate lesions to which this therapy can be applied.”

Thrombectomy with aspiration of thrombus prior to PCI is thought to prevent distal embolization and improve microvascular perfusion. But although electrocardiographic and angiographic outcomes improve with thrombectomy, such as an increased ST-segment resolution and a decreased distal embolization, no clinical benefits have been shown. One recent large study even found that the risk of stroke actually increased by 66%.

Related Links:

University College London
University of Manchester



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.